Published in Immunology on August 01, 1982
Aerobic glycolysis by proliferating cells: protection against oxidative stress at the expense of energy yield. J Bioenerg Biomembr (1997) 1.05
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci (1964) 127.96
A procedure for removing red cells and dead cells from lymphoid cell suspensions. J Immunol Methods (1975) 4.22
A rapid method for the separation of functional lymphoid cell populations of human and animal origin on PVP-silica (Percoll) density gradients. Scand J Immunol (1979) 2.35
Insulin-like activity of concanavalin A and wheat germ agglutinin--direct interactions with insulin receptors. Proc Natl Acad Sci U S A (1973) 2.19
Molecular basis of insulin action. Annu Rev Biochem (1977) 2.16
Mechanism of thymus-independent immunocyte triggering. Mitogenic activation of B cells results in specific immune responses. J Exp Med (1974) 2.04
H-2 antigen-specific cytotoxic T cells induced by concanavalin A: estimation of their relative frequency. Eur J Immunol (1976) 1.95
Emergence of insulin receptors on human lymphocytes during in vitro transformation. Proc Natl Acad Sci U S A (1972) 1.58
Triggering mechanism of B lymphocytes. I. Effect of anti-immunoglobulin and enhancing soluble factor on differentiation and proliferation of B cells. J Immunol (1975) 1.53
Role of protein and RNA synthesis in the development of insulin binding sites on activated thymus-derived lymphocytes. J Biol Chem (1979) 1.22
Modulation of the phosphorylation state of rat liver pyruvate kinase by allosteric effectors and insulin. J Biol Chem (1979) 1.14
The insulin receptor as a universal marker of activated lymphocytes. Eur J Immunol (1978) 1.04
The role of insulin in the response of murine T lymphocytes to mitogenic stimulation in vitro. J Immunol (1980) 0.90
The specificity of nonspecific concanavalin A-induced helper factors. Eur J Immunol (1979) 0.88
Development of B cell subsets: effect of priming on in vitro TNP-LPS responsiveness. J Immunol (1978) 0.86
Insulin receptors and the site of action of insulin. Life Sci (1978) 0.86
Changes in glycolytic enzyme levels and isozyme expression in human lymphocytes during blast transformation. Arch Biochem Biophys (1977) 0.85
Glucocorticoids and lymphocytes. I. Increased glucocorticoid receptor levels in antigen-stimulated lymphocytes. J Immunol (1980) 0.85
Activation of early enzyme production in small lymphocytes in response to high, nonmitogenic concentrations of concanavalin A. Proc Natl Acad Sci U S A (1980) 0.81
Cyclic guanosine 3',5'-monophosphate and phosphodiesterase activity in mitogen-stimulated human lymphocytes. Biochem Biophys Res Commun (1979) 0.78
An association between viral genes and human oncogenic alterations: the adenovirus E1A induces the Ewing tumor fusion transcript EWS-FLI1. Nat Med (1999) 3.27
IL-2 protects against anti-CD3-induced cell death in human medullary thymocytes. J Immunol (1990) 1.08
Development of B cell subsets: effect of priming on in vitro TNP-LPS responsiveness. J Immunol (1978) 0.86
Metabolic control of glycolysis in normal and tumor permeabilized cells. Cancer Res (1978) 0.83
Production of antigen-specific human monoclonal antibodies: comparison of mice carrying IgH/kappa or IgH/kappa/lambda transloci. Biotechniques (2002) 0.79
Proliferative responses induced by the activation of protein kinase C during the development of human T lymphocytes. Eur J Immunol (1991) 0.78
Effect of purified human interferon-alpha on the expression of differentiation antigens and mitogen reactivity of cultured human thymic cells. Cell Immunol (1986) 0.77
Differentiation of B-cell subsets after antigen priming. Cell Immunol (1979) 0.75
Immunoglobulin receptor evolution in follicular lymphoma and a review of literature. Leuk Lymphoma (2007) 0.75
Different macrophage requirement in the specific and polyclonal responses induced by TNP-LPS and LPS. Scand J Immunol (1980) 0.75
Quantitative determination of the degree of differentiation of mammary tumors by pyruvate kinase kinetic analysis. Cancer Res (1981) 0.75